Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nutrition
Metadata
Title
Energy utilization of retrograded starch by sows
Authors
H.L. Müller
M. Kirchgeßner
Publication date
01-12-1998
Publisher
Steinkopff-Verlag
Published in
European Journal of Nutrition / Issue 4/1998
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s003940050035

Other articles of this Issue 4/1998

European Journal of Nutrition 4/1998 Go to the issue

Original contribution

Supplements as a source of micronutrient intake in middle-aged men in southern Germany: Results of the MONICA dietary survey 1994/95

Original contribution

Are patients with chronic renal failure (CRF) deficient in Biotin and is regular Biotin supplementation required?

Original contribution

Incorporation of urea nitrogen into fecal protein and plasma protein amino acids in elderly human volunteers after ingestion of lactic acid bacteria

Original contribution

Diurnal pattern of choline concentrations in serum of pigs as influenced by dietary choline or lecithin intake

Original contribution

Small intestinal transit and digestibility of lactitol in Wistar rats

Invited review

Nutritional Epidemiology: It's role in nutritional science and future perspectives

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits